Global Circulating Cell-Free DNA Diagnostics Market
According to a new market research report published by Global Market Estimates, the Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market is projected to grow from USD 4.9 billion in 2022 to USD 13.1 billion in 2027 at a CAGR of 21.7% from 2022 to 2027. Hoffmann-La Roche, Natera Inc., Illumina Inc., Agena Bioscience, Paragon Genomics, Thermo Fisher Scientific, Bio-Rad Laboratories, Lucence Health, and Eurofins among others are some key players in the circulating cell-free DNA (ccfDNA) diagnostics market.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and indepth TOC on “Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/circulatingcell-free-dna-ccfdna-diagnostics-market-3851
By Application (Non-invasive Prenatal Testing, Cancer Diagnostics, Others), By End-Use (Hospitals & Prenatal Clinics, Diagnostic Centers, Academic & Government Institutes, Biotechnology & Pharmaceutical Companies), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis Application Outlook (Revenue, USD Billion, 2022-2027)
Non-invasive Prenatal Testing Cancer Diagnostics Others
Type Outlook (Revenue, USD Billion, 2022-2027)
Hospitals & Prenatal Clinics Diagnostic Centers Academic & Government Institutes Biotechnology & Pharmaceutical Companies
Regional Outlook (Revenue, USD Billion, 2022-2027) North America
The U.S. Canada Mexico
Europe
Germany UK France Spain Italy Rest of Europe
Asia Pacific
China India Japan South Korea Australia Rest of APAC
Central & South America
Brazil Argentina Rest of CSA
Middle East & Africa
Saudi Arabia South Africa Rest of MEA
Contact: Yash Jain Email address: yash.jain@globalmarketestimates.com Phone Number: +1 6026667238